All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0601 | Anti-COTL1 (CBXC-1958) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-1958 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4025 | Anti-COTL1 (CBXC-1958) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-1958 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2931 | Anti-COTL1 (CBFYC-0391) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-0391 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2932 | Anti-COTL1 (CBFYC-2110) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2110 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2933 | Anti-COTL1 (CBFYC-2111) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2111 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6184 | Anti-COTL1 (CBFYC-0391) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-0391 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6185 | Anti-COTL1 (CBFYC-2110) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2110 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6186 | Anti-COTL1 (CBFYC-2111) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2111 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0544 | Anti-COTL1 (AT1D6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | AT1D6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2836 | Anti-COTL1 (AT1D6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | AT1D6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION